{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T11:11:05Z","timestamp":1777979465098,"version":"3.51.4"},"reference-count":20,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>This study reports a previously unreported heterozygous MYCN missense variant, c.454G&gt;A (p.Ala152Thr), identified in a child and two affected relatives, with clinical findings consistent with Feingold syndrome type 1, an autosomal dominant developmental disorder most commonly caused by loss-of-function variants in MYCN. The proband presented with a cleft palate, craniofacial dysmorphism, feeding difficulties, hypotonia, and characteristic digital anomalies. Similar features were observed in the father and sibling. Clinical exome sequencing revealed the novel MYCN variant, which was confirmed by Sanger sequencing and demonstrated co-segregation with the phenotype. Although most pathogenic MYCN variants leading to FS1 truncate the protein, this missense change lies within the N-terminal transactivation domain, a region involved in transcriptional regulation and protein stability. The physicochemical alteration introduced at residue Ala152 may plausibly affect MYCN function, consistent with haploinsufficiency as the established disease mechanism. According to the 2024 ACGS Best Practice Guidelines, the variant was classified as a variant of uncertain significance leaning toward pathogenicity. This report expands the mutational spectrum of MYCN, supports the potential clinical relevance of N-terminal missense variation in MYCN, and highlights intrafamilial phenotypic variability in FS1.<\/jats:p>","DOI":"10.3390\/genes17050552","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T10:01:30Z","timestamp":1777975290000},"page":"552","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Expanding the MYCN Variant Spectrum in Feingold Syndrome Type 1: A Novel N-Terminal Missense Variant Segregating in an Affected Family"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1545-3665","authenticated-orcid":false,"given":"Francisco","family":"Javier M\u00e9rida De la Torre","sequence":"first","affiliation":[{"name":"Genetics Laboratory, Hospital Regional Universitario, 29011 M\u00e1laga, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Porta Pelayo","sequence":"additional","affiliation":[{"name":"Genologica by Health in Code, 29016 M\u00e1laga, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inmaculada","family":"Ortiz-Mart\u00edn","sequence":"additional","affiliation":[{"name":"Genologica by Health in Code, 29016 M\u00e1laga, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,5]]},"reference":[{"key":"ref_1","unstructured":"Adam, M.P., Bick, S., Mirzaa, G.M., Pagon, R.A., Wallace, S.E., and Amemiya, A. (2009). Feingold Syndrome 1. GeneReviews\u00ae, University of Washington."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1136\/jmg.28.6.389","article-title":"Autosomal dominant inheritance of abnormalities of the hands and feet with short palpebral fissures, variable microcephaly with learning disability, and oesophageal\/duodenal atresia","volume":"28","author":"Brunner","year":"1991","journal-title":"J. Med. Genet."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/(SICI)1096-8628(19970331)69:3<245::AID-AJMG7>3.0.CO;2-K","article-title":"Syndrome of microcephaly, facial and hand abnormalities, tracheoesophageal fistula, duodenal atresia, and developmental delay","volume":"69","author":"Feingold","year":"1997","journal-title":"Am. J. Med. Genet."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1086\/302779","article-title":"Familial syndromic esophageal atresia maps to 2p23-p24","volume":"66","author":"Celli","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/ng1546","article-title":"MYCN haploinsufficiency is associated with reduced brain size and intestinal atresias in Feingold syndrome","volume":"37","author":"Celli","year":"2005","journal-title":"Nat. Genet."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/humu.20750","article-title":"Genotype-phenotype correlations in MYCN-related Feingold syndrome","volume":"29","author":"Marcelis","year":"2008","journal-title":"Hum. Mutat."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1002\/ajmg.a.40355","article-title":"Features of Feingold syndrome 1 dominate in subjects with 2p deletions including MYCN","volume":"176","author":"Burnside","year":"2018","journal-title":"Am. J. Med. Genet. Part A"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/ajmg.a.61037","article-title":"Growth hormone deficiency, aortic dilation, and neurocognitive issues in Feingold syndrome 2","volume":"179","author":"Muriello","year":"2019","journal-title":"Am. J. Med. Genet. Part A"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e05886","DOI":"10.1002\/ccr3.5886","article-title":"A new variant of MYCN gene as a cause of Feingold syndrome","volume":"10","author":"Zeka","year":"2022","journal-title":"Clin. Case Rep."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Ruiz-P\u00e9rez, M.V., Henley, A.B., and Arsenian-Henriksson, M. (2017). The MYCN Protein in Health and Disease. Genes, 8.","DOI":"10.3390\/genes8040113"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1242\/dev.000703","article-title":"Activities of N-Myc in the developing limb link control of skeletal size with digit separation","volume":"134","author":"Ota","year":"2007","journal-title":"Development"},{"key":"ref_12","first-page":"100238","article-title":"Gain-of-function MYCN causes a megalencephaly-polydactyly syndrome manifesting mirror phenotypes of Feingold syndrome","volume":"4","author":"Nishio","year":"2023","journal-title":"HGG Adv."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/ng.915","article-title":"Germline deletion of the miR-17~92 cluster causes skeletal and growth defects in humans","volume":"43","author":"Yao","year":"2011","journal-title":"Nat. Genet."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/ajmg.a.35781","article-title":"De novo 13q31.1\u2013q32.1 interstitial deletion encompassing the miR-17-92 cluster in a patient with Feingold syndrome-2","volume":"161","author":"Tassano","year":"2013","journal-title":"Am. J. Med. Genet. Part A"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"ref_16","unstructured":"Durkie, M., Cassidy, E.J., Berry, I., Owens, M., Turnbull, C., Scott, R.H., Taylor, R.W., Deans, Z.C., Ellard, S., and Baple, E.L. (2024). ACGS Best Practice Guidelines for Variant Classification in Rare Disease 2024. Assoc. Clin. Genom. Sci., Available online: https:\/\/www.genomicseducation.hee.nhs.uk\/wp-content\/uploads\/2024\/08\/ACGS-2024_UK-practice-guidelines-for-variant-classification.pdf."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"623679","DOI":"10.3389\/fonc.2020.623679","article-title":"Targeting MYCN in Pediatric and Adult Cancers","volume":"10","author":"Liu","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1002\/ajmg.a.32444","article-title":"Feingold syndrome associated with two novel MYCN mutations in sporadic and familial cases including monozygotic twins","volume":"146A","author":"Blaumeiser","year":"2008","journal-title":"Am. J. Med. Genet. Part A"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/ejhg.2010.225","article-title":"Dissection of the MYCN locus in Feingold syndrome and isolated oesophageal atresia","volume":"19","author":"Cognet","year":"2011","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/MCD.0000000000000342","article-title":"A novel mutation in MYCN gene causing congenital absence of the flexor pollicis longus tendon as an unusual presentation of Feingold syndrome 1","volume":"30","author":"Peleg","year":"2021","journal-title":"Clin. Dysmorphol."}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/17\/5\/552\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T10:15:14Z","timestamp":1777976114000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/17\/5\/552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,5]]},"references-count":20,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["genes17050552"],"URL":"https:\/\/doi.org\/10.3390\/genes17050552","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,5]]}}}